Staff Computational Biologist
Job Description
Key Skills Required
Master these to land this role
Want to know if you're a match for this job?
About this opportunity:
At Freenome, we are seeking a seasoned Staff Computational Biologist to help grow the Freenome Computational Science team. The ideal candidate is an expert in computational biology, genomics, and modeling, with a proven track record in industry settings. In this role, you will apply your background in computational biology and statistics to drive the creation of new applications and enhance algorithms for identifying molecular signatures of cancer. You will collaborate closely with machine learning scientists and computational biologists to iteratively advance computational models and assays, playing a key role in bringing products to the clinic. By joining us, you will have a significant impact on the continued growth of an organization dedicated to changing the entire landscape of cancer.
The role reports to the Manager and Staff Computational Biologist leading genomics modeling within Computational Science. This position can be onsite, hybrid, or remote (US only), based out of our campus in Brisbane, California.
What you’ll do:
- Serve as a key thought-leader on the Computational Science team, leading the analysis and interpretation of cancer's molecular signatures and staying current with the field.
- Guide and contribute to the development of models that characterize biological changes associated with cancer.
- Execute rigorous computational analyses on data from best-in-class molecular assays, including whole genome sequencing, whole genome bisulfite sequencing, targeted sequencing, RNA sequencing, and protein quantitation.
- Design novel statistical models for the evaluation, characterization, and modeling of these data types within the context of cancer biology and progression.
- Identify research hypotheses and potential areas for model improvement; plan, scope, and execute associated research projects with a skilled team of computational biologists.
- Solve complex analytical challenges inherent to the study of cell-free circulating nucleic acids and proteins.
- Partner closely with molecular biologists to collaboratively refine wet lab experiments, and with development scientists to turn research models into products.
- Support the professional development and career growth of talented, cross-functional computational biologists within your team.
Must haves:
- PhD or equivalent experience in a relevant quantitative field (e.g., computational biology, cancer biology, statistics, bioinformatics).
- At least 8 years of post-PhD experience applying computational techniques for biological discovery and product development, preferably in cancer or diagnostics within an industry setting.
- Deep expertise in cancer and molecular biology, with a proven ability to leverage this knowledge for computational biology and diagnostics problems in cancer.
- Extensive experience analyzing data and developing models for high-throughput, quantitative technologies in genomics, epigenomics, transcriptomics, proteomics, (e.g., Methyl-seq, ATAC-seq, RNA-seq, Hi-C, immunodetection assays).
- Proficiency in computational and programming skills, including extensive experience with Python statistical packages (Numpy, Matplotlib, Pandas) and modeling packages (Scikit-learn, TensorFlow, PyTorch) or equivalents in languages like R or C/C++.
How would you rate this job post?
See what other professionals think about this role.
Similar Opportunities
More Openings at Freenome
Explore Top Companies in this Space
BeOne Medicines
Biotechnology / Pharmaceuticals / Oncology
Veracyte
Biotechnology / HealthTech / Molecular Diagnostics
Revvity
Life Sciences / Biotechnology / Clinical Diagnostics
Karius
Biotechnology Research / Diagnostics / Genomics / Life Sciences
Freenome
View Company ProfileFreenome (operating under freenome.com) is a high-growth biotechnology and molecular diagnostics company that utilizes a proprietary AI-driven multiomics platform to pioneer non-invasive blood tests for early-stage cancer detection. Founded in 2014, the company shifts the paradigm of cancer screening away from isolated, single-analyte genomic testing. Instead, Freenome's platform integrates cell-free DNA (cfDNA), methylation patterns, genomic fragments, and programmatic protein biomarkers with advanced machine learning models to capture complex tumor signals and systemic immune responses at their earliest, most treatable stages. The company's foundational asset, the SimpleScreen colorectal cancer screening blood test, demonstrated exceptional clinical validation through its massive, prospective PREEMPT CRC clinical trial published in JAMA, meeting major efficacy endpoints for sensitivity and specificity. Capitalizing on this multiomic infrastructure, Freenome is aggressively scaling its diagnostic pipeline into a comprehensive Multi-Cancer Early Detection (MCED) portfolio targeting lung, pancreatic, and other high-mortality malignancies. Freenome has secured monumental, multi-million-dollar strategic commercialization and technology agreements with dominant industry pioneers, including a major global expansion partnership with Roche and an extensive distribution and licensing framework with Exact Sciences. Backed by over $1.4 billion in total funding from premier healthcare, tech, and life sciences institutional investors—including Andreessen Horowitz, Bain Capital Life Sciences, RA Capital, and Perceptive Advisors—Freenome entered into a definitive business combination agreement with Perceptive Capital Solutions Corp in late 2025 to transition into a publicly traded entity on the Nasdaq under the ticker FRNM. Headquartered in Brisbane, California, the organization operates sophisticated, CLIA-certified laboratory facilities and is led by industry veteran Dr. Aaron Elliott as Chief Executive Officer.
Safety First
- Never pay for a job application.
- Do not share sensitive bank info.
- Verify the client before starting work.
